Latest MedImmune Stories
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, May 20, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts'
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
The Department of Economic Development for the City of Frederick is proud to announce that AstraZeneca, and its global biologics research and development arm MedImmune, received an “Economic
- Five Joint Research Projects Underway - GAITHERSBURG, Md.
RMB 60 Million Free Grant for Construction of Dedicated Production Facility BEIJING, April 24, 2014 /PRNewswire/ -- Sinovac Biotech Ltd.
ROCKVILLE, Md., April 8, 2014 /PRNewswire/ -- Biologics development and manufacturing services provider Omnia Biologics, Inc.
NES ZIONA, Israel, April 2, 2014 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd (TASE: BNDX), developer of a universal flu vaccine, announced today that its Board of Directors has approved
-- Conference Call Today, March 31, 2014, at 10:00 a.m. (EDT) -- ROCKVILLE, Md., March 31, 2014 /PRNewswire/ -- Synthetic Biologics, Inc.
LONDON and BOSTON, March 26, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that a company